Literature DB >> 10037151

Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase.

A Kaasik1, A Minajeva, E De Sousa, R Ventura-Clapier, V Veksler.   

Abstract

Nitric oxide biosynthesis in cardiac muscle leads to a decreased oxygen consumption and lower ATP synthesis. It is suggested that this effect of nitric oxide is mainly due to the inhibition of the mitochondrial respiratory chain enzyme, cytochrome c oxidase. However, this work demonstrates that nitric oxide is able to inhibit soluble mitochondrial creatine kinase (CK), mitochondrial CK bound in purified mitochondria, CK in situ in skinned fibres as well as the functional activity of mitochondrial CK in situ in skinned fibres. Since mitochondrial isoenzyme is functionally coupled to oxidative phosphorylation, its inhibition also leads to decreased sensitivity of mitochondrial respiration to ADP and thus decreases ATP synthesis and oxygen consumption under physiological ADP concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037151     DOI: 10.1016/s0014-5793(99)00033-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  ATP-sensitive potassium channels in capillaries isolated from guinea-pig heart.

Authors:  M Mederos y Schnitzler; C Derst; J Daut; R Preisig-Müller
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

2.  Inhibition of nitric oxide synthase by L-NAME speeds phase II pulmonary .VO2 kinetics in the transition to moderate-intensity exercise in man.

Authors:  Andrew M Jones; Daryl P Wilkerson; Katrien Koppo; Sally Wilmshurst; Iain T Campbell
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

Review 3.  CK flux or direct ATP transfer: versatility of energy transfer pathways evidenced by NMR in the perfused heart.

Authors:  F Joubert; P Mateo; B Gillet; J C Beloeil; J L Mazet; J A Hoerter
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

Review 4.  Slow VO₂ kinetics during moderate-intensity exercise as markers of lower metabolic stability and lower exercise tolerance.

Authors:  Bruno Grassi; Simone Porcelli; Desy Salvadego; Jerzy A Zoladz
Journal:  Eur J Appl Physiol       Date:  2010-09-07       Impact factor: 3.078

5.  Faster O₂ uptake kinetics in canine skeletal muscle in situ after acute creatine kinase inhibition.

Authors:  Bruno Grassi; Harry B Rossiter; Michael C Hogan; Richard A Howlett; James E Harris; Matthew L Goodwin; John L Dobson; L Bruce Gladden
Journal:  J Physiol       Date:  2010-11-08       Impact factor: 5.182

6.  Effects of glutamine and hyperoxia on pulmonary oxygen uptake and muscle deoxygenation kinetics.

Authors:  Simon Marwood; Joanna L Bowtell
Journal:  Eur J Appl Physiol       Date:  2006-11-09       Impact factor: 3.078

7.  Intracellular energetic units in healthy and diseased hearts.

Authors:  Enn K Seppet; Margus Eimre; Tiia Anmann; Evelin Seppet; Nadezhda Peet; Tuuli Käämbre; Kalju Paju; Andres Piirsoo; Andrei V Kuznetsov; Marko Vendelin; Frank N Gellerich; Stephan Zierz; Valdur A Saks
Journal:  Exp Clin Cardiol       Date:  2005

8.  Sodium nitrate supplementation alters mitochondrial H2O2 emission but does not improve mitochondrial oxidative metabolism in the heart of healthy rats.

Authors:  Cynthia M F Monaco; Paula M Miotto; Jason S Huber; Luc J C van Loon; Jeremy A Simpson; Graham P Holloway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-07       Impact factor: 3.619

Review 9.  Oxygen uptake kinetics: old and recent lessons from experiments on isolated muscle in situ.

Authors:  Bruno Grassi
Journal:  Eur J Appl Physiol       Date:  2003-10-11       Impact factor: 3.078

10.  Dichloroacetate does not speed phase-II pulmonary VO2 kinetics following the onset of heavy intensity cycle exercise.

Authors:  Andrew M Jones; Katrien Koppo; Daryl P Wilkerson; Sally Wilmshurst; Iain T Campbell
Journal:  Pflugers Arch       Date:  2003-12-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.